JP2012513398A5 - - Google Patents

Download PDF

Info

Publication number
JP2012513398A5
JP2012513398A5 JP2011542470A JP2011542470A JP2012513398A5 JP 2012513398 A5 JP2012513398 A5 JP 2012513398A5 JP 2011542470 A JP2011542470 A JP 2011542470A JP 2011542470 A JP2011542470 A JP 2011542470A JP 2012513398 A5 JP2012513398 A5 JP 2012513398A5
Authority
JP
Japan
Prior art keywords
phenoxy
carboxylic acid
chroman
ylcarbamoyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011542470A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012513398A (ja
JP5575799B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/068672 external-priority patent/WO2010075200A1/en
Publication of JP2012513398A publication Critical patent/JP2012513398A/ja
Publication of JP2012513398A5 publication Critical patent/JP2012513398A5/ja
Application granted granted Critical
Publication of JP5575799B2 publication Critical patent/JP5575799B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011542470A 2008-12-22 2009-12-18 7−フェノキシクロマンカルボン酸誘導体 Expired - Fee Related JP5575799B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13998108P 2008-12-22 2008-12-22
US61/139,981 2008-12-22
PCT/US2009/068672 WO2010075200A1 (en) 2008-12-22 2009-12-18 7-phenoxychroman carboxylic acid derivatives

Publications (3)

Publication Number Publication Date
JP2012513398A JP2012513398A (ja) 2012-06-14
JP2012513398A5 true JP2012513398A5 (enExample) 2013-01-31
JP5575799B2 JP5575799B2 (ja) 2014-08-20

Family

ID=42060604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011542470A Expired - Fee Related JP5575799B2 (ja) 2008-12-22 2009-12-18 7−フェノキシクロマンカルボン酸誘導体

Country Status (7)

Country Link
US (1) US8785445B2 (enExample)
EP (1) EP2379535B1 (enExample)
JP (1) JP5575799B2 (enExample)
CN (1) CN102325767B (enExample)
CA (1) CA2748099C (enExample)
TW (1) TWI469977B (enExample)
WO (1) WO2010075200A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53665B1 (sr) * 2008-06-25 2015-04-30 Array Biopharma Inc. Derivati 6-supstituisane fenoksihroman karboksilne kiseline
ES2921576T3 (es) 2008-12-19 2022-08-29 Vertex Pharma Compuestos útiles como inhibidores de la quinasa ATR
EP2569313A1 (en) 2010-05-12 2013-03-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
US9334244B2 (en) 2010-05-12 2016-05-10 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
EP3878851A1 (en) 2011-09-30 2021-09-15 Vertex Pharmaceuticals Incorporated Process for making compounds useful as inhibitors of atr kinase
RU2018108589A (ru) 2011-09-30 2019-02-25 Вертекс Фармасьютикалз Инкорпорейтед Лечение рака поджелудочной железы и немелкоклеточного рака легкого ингибиторами atr
PT2833973T (pt) 2012-04-05 2017-12-21 Vertex Pharma Compostos úteis como inibidores da cinase atr e terapias de combinação dos mesmos
CN104583194A (zh) 2012-05-11 2015-04-29 艾伯维公司 作为nampt抑制剂的哒嗪和吡啶衍生物
TWI654180B (zh) 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
WO2014055756A1 (en) 2012-10-04 2014-04-10 Vertex Pharmaceuticals Incorporated Method for measuring atr inhibition mediated increases in dna damage
ES2991300T3 (es) * 2015-02-13 2024-12-03 Inserm Institut Nat De La Sante Et De Larecherche Medicale Antagonistas de PTGDR-1 y/o PTGDR-2 para prevenir y/o tratar lupus eritematoso sistémico
EP3355926B1 (en) 2015-09-30 2025-12-24 Vertex Pharmaceuticals Inc. Combination of dna damaging agents and atr inhibitors for use in a method for treating cancer using
WO2021063735A1 (en) 2019-10-02 2021-04-08 Basf Se New bicyclic pyridine derivatives
CN111228247B (zh) * 2019-12-05 2023-01-31 青海大学 一种用于治疗包虫病的含苯亚甲基丙酮药物及其制备方法
CA3249692A1 (en) * 2022-04-19 2023-10-26 Gilgamesh Pharmaceuticals, Inc. PYRIDINE DERIVATIVES FOR THE TREATMENT OF PSYCHIATRIC DISORDERS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070119975A1 (en) * 2001-11-28 2007-05-31 Hunnicutt S B Method and Apparatus for Reducing the Precipitation Rate of an Irrigation Sprinkler
AU2003297398B2 (en) * 2002-12-20 2009-09-24 Amgen Inc. Asthma and allergic inflammation modulators
GB0611781D0 (en) 2006-06-14 2006-07-26 Argenta Discovery Ltd 2-Oxo-2H-Chromene Compounds
AU2007286829B2 (en) * 2006-08-21 2013-05-02 Array Biopharma, Inc. 4-substituted phenoxyphenylacetic acid derivatives
US8039484B2 (en) 2006-10-31 2011-10-18 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
WO2009061730A2 (en) 2007-11-05 2009-05-14 Array Biopharma Inc. 4-heteroaryl-substituted phenoxyphenylacetic acid
RS53665B1 (sr) * 2008-06-25 2015-04-30 Array Biopharma Inc. Derivati 6-supstituisane fenoksihroman karboksilne kiseline

Similar Documents

Publication Publication Date Title
JP2012513398A5 (enExample)
TWI579284B (zh) 咪唑并吡咯啶酮化合物
CA2742007C (en) Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
AU2016276806B2 (en) Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
JP5797345B2 (ja) プロテインキナーゼに対する阻害活性を有するチエノ[3,2−d]ピリミジン誘導体
RU2586974C2 (ru) Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств
JP5543980B2 (ja) 新規抗血小板薬
KR102007056B1 (ko) 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸
AU2014219855B2 (en) Trk-inhibiting compound
CN103497188B (zh) 调节c‑fms和/或c‑kit活性的化合物及其应用
JP5974124B2 (ja) キナーゼ阻害剤の組成物ならびに癌およびキナーゼに関連する他の疾患の治療のためのそれらの使用
JP7007290B2 (ja) デングウイルス複製阻害剤としての置換インドール化合物誘導体
KR20020063934A (ko) 코르티코트로핀 방출 인자 길항제
JP2017526622A (ja) 3−アミノ−1,5,6,7−テトラヒドロ−4h−インドール−4−オン類
KR20150135359A (ko) 브로모도메인-함유 단백질의 억제를 위한 방법 및 조성물
JP2009529047A5 (enExample)
TW200536851A (en) Compounds and methods of use
RU2006112046A (ru) Производные пиррола с антибактериальным действием
WO2014164767A1 (en) Novel compounds and compositions for inhibition of fasn
JP2010522765A5 (enExample)
AU2013331505A1 (en) Phenyl linked quinolinyl modulators of ROR-gamma-t
JP2011509301A5 (enExample)
JP2019505595A5 (enExample)
JP2013519724A5 (enExample)
JP2006507355A5 (enExample)